DNABW (Ginkgo Bioworks Holdings) Beginning Cash Position: $212.37 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DNABW Ginkgo Bioworks Holdings Inc DNABW
61 GF Score
Price $0.00
! 5 Warning Signs
View Full Analysis

What is Ginkgo Bioworks Holdings Beginning Cash Position?

Ginkgo Bioworks Holdings DNABW -14.29% 61 Beginning Cash Position is $212.37 Mil as of Mar. 2026. GuruFocus rates DNABW with a GF Score™ of 61/100. The stock has 5 warning signs investors should review.

Ginkgo Bioworks Holdings's Beginning Cash Position for the quarter that ended in Mar. 2026 was $212.37 Mil.

Ginkgo Bioworks Holdings's quarterly Beginning Cash Position declined from Sep. 2025 ($251.35 Mil) to Dec. 2025 ($156.96 Mil) but then increased from Dec. 2025 ($156.96 Mil) to Mar. 2026 ($212.37 Mil).

Ginkgo Bioworks Holdings's annual Beginning Cash Position declined from Dec. 2023 ($1,369.58 Mil) to Dec. 2024 ($989.58 Mil) and declined from Dec. 2024 ($989.58 Mil) to Dec. 2025 ($605.74 Mil).

Ginkgo Bioworks Holdings Beginning Cash Position Related Terms

Ginkgo Bioworks Holdings Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Ginkgo Bioworks Holdings's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ginkgo Bioworks Holdings Beginning Cash Position Chart

Ginkgo Bioworks Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial 385.88 1,592.93 1,369.58 989.58 605.74

Ginkgo Bioworks Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 605.74 355.41 251.35 156.96 212.37
DNABW
61GF Score
Ginkgo Bioworks Holdings Inc DNABW
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ginkgo Bioworks Holdings Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of $212.37 Mil mean?
Ginkgo Bioworks Holdings (DNABW) has a Beginning Cash Position of $212.37 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Ginkgo Bioworks Holdings and its competitors.
Is Ginkgo Bioworks Holdings' Beginning Cash Position too high?
Ginkgo Bioworks Holdings' current Beginning Cash Position is $212.37 Mil. Overall, Ginkgo Bioworks Holdings has a GF Score™ of 61/100, reflecting its overall financial health beyond just this single metric.
How does Ginkgo Bioworks Holdings' Beginning Cash Position compare to AGMB and ACRS?
Ginkgo Bioworks Holdings' Beginning Cash Position of $212.37 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Ginkgo Bioworks Holdings and its competitors. Ginkgo Bioworks Holdings's current Beginning Cash Position is $212.37 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ginkgo Bioworks Holdings stock overvalued right now?
Ginkgo Bioworks Holdings (DNABW) has a current Beginning Cash Position of $212.37 Mil. The current Beginning Cash Position is $212.37 Mil. Ginkgo Bioworks Holdings' overall GF Score™ is 61/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Ginkgo Bioworks Holdings (DNABW), the current Beginning Cash Position is $212.37 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ginkgo Bioworks Holdings Business Description

Other Exchanges DNA:USADNA:Mexico
Address 27 Drydock Avenue, 8th Floor, Boston, MA, USA, 02210
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
61GF Score

Get the complete analysis for DNABW

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price